Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
CD4(+) T cells
CD8(+) T cells
Cancer immunotherapy
Dendritic cells
Dexosomes
NK cells
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
28 05 2023
28 05 2023
Historique:
received:
20
01
2023
revised:
25
03
2023
accepted:
03
04
2023
medline:
28
4
2023
pubmed:
10
4
2023
entrez:
9
4
2023
Statut:
ppublish
Résumé
Dendritic cells (DCs) release nanometer-sized membrane vesicles known as dexosomes, containing different molecules, particularly proteins, for presenting antigens, i.e., major histocompatibility complex (MHC)-I/II and CD86. Dexosomes can, directly and indirectly, stimulate antigen-reactive CD8
Identifiants
pubmed: 37031915
pii: S0304-3835(23)00119-2
doi: 10.1016/j.canlet.2023.216168
pii:
doi:
Substances chimiques
Cancer Vaccines
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
216168Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.